Probiotics and Pregnancy

Current Diabetes Reports

Volumn 15, Issue 1, 2015, Pages

  Gomez Arango, Luisa F ^a,b   Barrett, Helen L ^a,b   Callaway, Leonie K ^a   Nitert, Marloes Dekker ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Infant outcomes; Maternal microbiome; Pregnancy; Pregnancy complications; Probiotics

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROBIOTIC AGENT; TRIACYLGLYCEROL;

ALLERGIC DISEASE; ASTHMA; BIFIDOBACTERIUM ANIMALIS; CHILD GROWTH; CHOLESTEROL BLOOD LEVEL; FOOD PROCESSING; HUMAN; INFANCY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS GASSERI; LACTOBACILLUS JENSENII; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; METAGENOMICS; NECROTIZING ENTEROCOLITIS; OBESITY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; REVIEW; STREPTOCOCCUS THERMOPHILUS; SUPPLEMENTATION; TRIACYLGLYCEROL BLOOD LEVEL; VAGINITIS; WEIGHT GAIN; ADULT; DIABETES, GESTATIONAL; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; MATERNAL NUTRITION; MICROBIOLOGY; NEWBORN; PLACENTA; PRE-ECLAMPSIA; PREGNANCY COMPLICATIONS; TREATMENT OUTCOME;

ADULT; DIABETES, GESTATIONAL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFANT, NEWBORN; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PROBIOTICS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 84911479214     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-014-0567-0     Document Type: Review

References (80)

1. Aagaard K, Riehle K, Ma J, Segata N, Mistretta T-A, Coarfa C, et al. A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS ONE. 2012;7(6):e36466. doi:10.1371/journal.pone.0036466. This study shows a complete comparative metagenomic characterization of the vaginal microbiota during pregnancy and non-pregnancy.
2. Koren O, Goodrich Julia K, Cullender Tyler C, Spor A, Laitinen K, Kling Bäckhed H, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150(3):470–80. doi:10.1016/j.cell.2012.07.008. The first approach showing the changes of the gut microbiota during pregnancy.
3. Laker RC, Wlodek ME, Connelly JJ, Yan Z. Epigenetic origins of metabolic disease: The impact of the maternal condition to the offspring epigenome and later health consequences. Food Sci Hum Wellness. 2013;2(1):1–11. doi:10.1016/j.fshw.2013.03.002.
4. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med. 2014;6(237):237ra65. doi:10.1126/scitranslmed.3008599. The first study to suggest that the placenta is not sterile, that it contains its own microbiome.
5. Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut microbiota: The hygiene hypothesis expanded? Diabetes Care. 2010;33(10):2277–84. doi:10.2337/dc10-0556.
6. Thum C, Cookson AL, Otter DE, McNabb WC, Hodgkinson AJ, Dyer J, et al. Can nutritional modulation of maternal intestinal microbiota influence the development of the infant gastrointestinal tract? J Nutr. 2012;142(11):1921–8. doi:10.3945/jn.112.166231.
7. Thomas DW, Greer FR. Probiotics and prebiotics in pediatrics. Pediatrics. 2010;126(6):1217–31. doi:10.1542/peds.2010-2548.
8. Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: The impact of probiotics. Genes Nutr. 2011;6(3):209–40. doi:10.1007/s12263-011-0229-7.
9. de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 2008;111:1–66. doi:10.1007/10_2008_097.
10. Taibi A, Comelli EM. Practical approaches to probiotics use. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. 2014:1-7. doi:10.1139/apnm-2013-0490.
11. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. The Cochrane database of systematic reviews. 2011(3):Cd005496. doi:10.1002/14651858.CD005496.pub3.
12. Critchfield JW, van Hemert S, Ash M, Mulder L, Ashwood P. The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract. 2011;2011:161358. doi:10.1155/2011/161358.
13. Gilbert Jack A, Krajmalnik-Brown R, Porazinska Dorota L, Weiss Sophie J, Knight R. Toward effective probiotics for autism and other neurodevelopmental disorders. Cell. 2013;155(7):1446–8. doi:10.1016/j.cell.2013.11.035.
14. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. doi:10.1038/nature08821.
15. Lee WJ, Hase K. Gut microbiota-generated metabolites in animal health and disease. Nat Chem Biol. 2014;10(6):416–24. doi:10.1038/nchembio.1535.
16. Harley IT, Karp CL. Obesity and the gut microbiome: Striving for causality. Mol Metabolism. 2012;1(1–2):21–31. doi:10.1016/j.molmet.2012.07.002.
17. Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol. 2012;9(4):219–30. doi:10.1038/nrgastro.2012.14.
18. Avershina E, Storro O, Oien T, Johnsen R, Pope P, Rudi K. Major faecal microbiota shifts in composition and diversity with age in a geographically restricted cohort of mothers and their children. FEMS Microbiol Ecol. 2014;87(1):280–90. doi:10.1111/1574-6941.12223.
19. Jost T, Lacroix C, Braegger C, Chassard C. Stability of the maternal gut microbiota during late pregnancy and early lactation. Curr Microbiol. 2014;68(4):419–27. doi:10.1007/s00284-013-0491-6.
20. Lamont RF, Sobel JD, Akins RA, Hassan SS, Chaiworapongsa T, Kusanovic JP, et al. The vaginal microbiome: New information about genital tract flora using molecular based techniques. BJOG Int J Obstet Gynaecol. 2011;118(5):533–49. doi:10.1111/j.1471-0528.2010.02840.x.
21. Romero R, Hassan SS, Gajer P, Tarca AL, Fadrosh DW, Nikita L, et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome. 2014;2(1):4. doi:10.1186/2049-2618-2-4.
22. Consortium HMP. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–14. doi:10.1038/nature11234.
23. Karnik S, Kanekar A. Childhood obesity: A global public health crisis. Int J Prev Med. 2012;3(1):1–7.
24. Rosenberg TJ, Garbers S, Lipkind H, Chiasson MA. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am J Public Health. 2005;95(9):1545–51. doi:10.2105/ajph.2005.065680.
25. Association AD. Gestational diabetes mellitus. Diabetes Care. 2004;27 Suppl 1:S88–90.
26. Van Lieshout RJ, Voruganti LP. Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: A review of the evidence and putative mechanisms. J Psychiatry Neurosci JPN. 2008;33(5):395–404.
27. Towpik I, Wender-Ozegowska E. Is diabetes mellitus worth treating? Ginekol Pol. 2014;85(3):220–5.
28. Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007;30(8):2070–6. doi:10.2337/dc06-2559a.
29. Halperin IJ, Feig DS. The role of lifestyle interventions in the prevention of gestational diabetes. Curr Diabetes Reports. 2014;14(1):452. doi:10.1007/s11892-013-0452-2.
30. Collado MC, Isolauri E, Laitinen K, Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr. 2008;88(4):894–9.
31. Collado MC, Isolauri E, Laitinen K, Salminen S. Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: A prospective follow-up study initiated in early pregnancy. Am J Clin Nutr. 2010;92(5):1023–30. doi:10.3945/ajcn.2010.29877.
32. Santacruz A, Collado MC, Garcia-Valdes L, Segura MT, Martin-Lagos JA, Anjos T, et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr. 2010;104(1):83–92. doi:10.1017/s0007114510000176.
33. Tilg H, Moschen AR. Microbiota and diabetes: An evolving relationship. Gut. 2014. doi:10.1136/gutjnl-2014-306928.
34. Ma J, Prince AL, Bader D, Hu M, Ganu R, Baquero K, et al. High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model. Nat Commun. 2014;5:3889. doi:10.1038/ncomms4889.
35. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–3. doi:10.1038/4441022a.
36. Conterno L, Fava F, Viola R, Tuohy KM. Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr. 2011;6(3):241–60. doi:10.1007/s12263-011-0230-1.
37. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010;5(2):e9085. doi:10.1371/journal.pone.0009085.
38. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60. doi:10.1038/nature11450.
39. Hu J, Nomura Y, Bashir A, Fernandez-Hernandez H, Itzkowitz S, Pei Z, et al. Diversified microbiota of meconium is affected by maternal diabetes status. PLoS One. 2013;8(11):e78257. doi:10.1371/journal.pone.0078257.
40. Ilmonen J, Isolauri E, Poussa T, Laitinen K. Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: A randomized placebo-controlled trial. Clin Nutr (Edinb Scotl). 2011;30(2):156–64. doi:10.1016/j.clnu.2010.09.009.
41. Luoto R, Laitinen K, Nermes M, Isolauri E. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: A double-blind, placebo-controlled study. Br J Nutr. 2010;103(12):1792–9. doi:10.1017/s0007114509993898. This is an important trial providing evidence of probiotics in the prevention of GDM.
42. Nitert MD, Barrett HL, Foxcroft K, Tremellen A, Wilkinson S, Lingwood B, et al. SPRING: An RCT study of probiotics in the prevention of gestational diabetes mellitus in overweight and obese women. BMC Pregnancy Childbirth. 2013;13:50. doi:10.1186/1471-2393-13-50.
43. Othman M, Neilson JP, Alfirevic Z. Probiotics for preventing preterm labour. The Cochrane database of systematic reviews. 2007(1):Cd005941. doi:10.1002/14651858.CD005941.pub2.
44. Rushing J, Neu J. Probiotics for pregnant women and preterm neonates. Am J Clin Nutr. 2011;93(1):3–4. doi:10.3945/ajcn.110.006346.
45. Othman M. ProB Trial: probiotics and the prevention of preterm labour; a randomised controlled trial protocol. WebmedCentral Obstetrics and Gynaecology 2012;3(6).
46. Vitali B, Cruciani F, Baldassarre ME, Capursi T, Spisni E, Valerii MC, et al. Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion. BMC Microbiol. 2012;12:236. doi:10.1186/1471-2180-12-236.
47. Polatti F. Bacterial vaginosis, Atopobium vaginae and nifuratel. Curr Clin Pharmacol. 2012;7(1):36–40.
48. Yang S, Li W, Challis JR, Reid G, Kim SO, Bocking AD. Probiotic Lactobacillus rhamnosus GR-1 supernatant prevents lipopolysaccharide-induced preterm birth and reduces inflammation in pregnant CD-1 mice. Am J Obstet Gynecol. 2014. doi:10.1016/j.ajog.2014.01.029.
49. Thompson ML, Ananth CV, Jaddoe VW, Miller RS, Williams MA. The association of maternal adult weight trajectory with preeclampsia and gestational diabetes mellitus. Paediatr Perinat Epidemiol. 2014. doi:10.1111/ppe.12128.
50. Hauth JC, Clifton RG, Roberts JM, Myatt L, Spong CY, Leveno KJ, et al. Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol. 2011;204(4):327.e1–6. doi:10.1016/j.ajog.2011.02.024.
51. Brantsaeter AL, Myhre R, Haugen M, Myking S, Sengpiel V, Magnus P, et al. Intake of probiotic food and risk of preeclampsia in primiparous women: The Norwegian Mother and Child Cohort Study. Am J Epidemiol. 2011;174(7):807–15. doi:10.1093/aje/kwr168. This cohort study shows that consumption of probiotic diary products is associated with reduced risk of preeclampsia.
52. Lye H-S, Rahmat-Ali GR, Liong M-T. Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract. Int Dairy J. 2010;20(3):169–75. doi:10.1016/j.idairyj.2009.10.003.
53. Ooi L-G, Liong M-T. Cholesterol-lowering effects of probiotics and prebiotics: A review of in vivo and in vitro findings. Int J Mol Sci. 2010;11(6):2499–522.
54. Asemi Z, Samimi M, Tabasi Z, Talebian P, Azarbad Z, Hydarzadeh Z, et al. Effect of daily consumption of probiotic yoghurt on lipid profiles in pregnant women: A randomized controlled clinical trial. J matern-fetal Neonatal Med Off J Eur Assoc Perinatal Med Fed Asia Ocean Perinatal Soc Int Soc Perinatal Obstet. 2012;25(9):1552–6. doi:10.3109/14767058.2011.640372.
55. Hoppu U, Isolauri E, Koskinen P, Laitinen K. Maternal dietary counseling reduces total and LDL cholesterol postpartum. Nutr (Burbank Los Angel County Calif). 2014;30(2):159–64. doi:10.1016/j.nut.2013.07.009.
56. Luoto R, Kalliomaki M, Laitinen K, Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (2005). 2010;34(10):1531–7. doi:10.1038/ijo.2010.50. This follow-up study shows that intake of probiotics during pregnancy and infancy can restrain excessive weight gain during the first years of life.
57. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. The Cochrane database of systematic reviews. 2007(4):Cd006475. doi:10.1002/14651858.CD006475.pub2.
58. Forno E, Onderdonk AB, McCracken J, Litonjua AA, Laskey D, Delaney ML, et al. Diversity of the gut microbiota and eczema in early life. Clin Mol Allergy CMA. 2008;6:11. doi:10.1186/1476-7961-6-11.
59. Gore C, Custovic A, Tannock GW, Munro K, Kerry G, Johnson K, et al. Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2012;42(1):112–22. doi:10.1111/j.1365-2222.2011.03885.x.
60. Bertelsen RJ, Brantsaeter AL, Magnus MC, Haugen M, Myhre R, Jacobsson B, et al. Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases. J Allergy Clin Immunol. 2014;133(1):165–71.e1-8. doi:10.1016/j.jaci.2013.07.032.
61. Ly NP, Litonjua A, Gold DR, Celedón JC. Gut microbiota, probiotics, and vitamin D: Interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol. 2011;127(5):1087–94. doi:10.1016/j.jaci.2011.02.015.
62. Doege K, Grajecki D, Zyriax BC, Detinkina E, Zu Eulenburg C, Buhling KJ. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood—a meta-analysis. Br J Nutr. 2012;107(1):1–6. doi:10.1017/s0007114511003400.
63. Wickens K, Stanley TV, Mitchell EA, Barthow C, Fitzharris P, Purdie G, et al. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2013;43(9):1048–57. doi:10.1111/cea.12154.
64. Loo EX, Llanora GV, Lu Q, Aw MM, Lee BW, Shek LP. Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: A 5-year follow-up. Int Arch Allergy Immunol. 2014;163(1):25–8. doi:10.1159/000356338.
65. Forsberg A, Abrahamsson TR, Bjorksten B, Jenmalm MC. Pre- and post-natal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2013;43(4):434–42. doi:10.1111/cea.12082.
66. Prescott SL, Wickens K, Westcott L, Jung W, Currie H, Black PN, et al. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clinical Exp Allergy J Br Soc Allergy Clin Immunol. 2008;38(10):1606–14. doi:10.1111/j.1365-2222.2008.03061.x.
67. Gloudemans AK, Lambrecht BN, Smits HH. Potential of immunoglobulin A to prevent allergic asthma. Clin Dev Immunol. 2013;2013:542091. doi:10.1155/2013/542091.
68. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. The Cochrane database of systematic reviews. 2014;4:Cd005496. doi:10.1002/14651858.CD005496.pub4.
69. Hartel C, Pagel J, Rupp J, Bendiks M, Guthmann F, Rieger-Fackeldey E, et al. Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very Low birth weight infants. J Pediatr. 2014. doi:10.1016/j.jpeds.2014.04.029.
70. Braga TD, da Silva GA, de Lira PI, de Carvalho LM. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: A double-blind, randomized, controlled trial. Am J Clin Nutr. 2011;93(1):81–6. doi:10.3945/ajcn.2010.29799.
71. Awad H, Mokhtar H, Imam SS, Gad GI, Hafez H, Aboushady N. Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates. Pak J Biol Sci PJBS. 2010;13(6):253–62.
72. Fernandez-Carrocera LA, Solis-Herrera A, Cabanillas-Ayon M, Gallardo-Sarmiento RB, Garcia-Perez CS, Montano-Rodriguez R, et al. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2013;98(1):F5–9. doi:10.1136/archdischild-2011-300435.
73. Boyle RJR-B, Roy M. Probiotic use in clinical practice: what are the risks? The American journal of clinical nutrition. 2006;83(6).
74. Elias J, Bozzo P, Einarson A. Are probiotics safe for use during pregnancy and lactation? Can Fam Phys Medecin de famille canadien. 2011;57(3):299–301.
75. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174–80. doi:10.1038/nature09944.
76. Mendz GL LS, Kaakoush NO, Quinlivan JA. Vaginal microbiome of pregnant women of three ethnic backgrounds in health and disease. In proceeding of: Perinatal Society of Australia and New Zealand Annual Scientific Meeting, At Perth, Western Australia. 2014.
77. Cho I, Blaser MJ. The human microbiome: At the interface of health and disease. Nat Rev Genet. 2012;13(4):260–70. doi:10.1038/nrg3182.
78. Guelinckx I, Devlieger R, Beckers K, Vansant G. Maternal obesity: pregnancy complications, gestational weight gain and nutrition. Obes Rev Off J Int Assoc Study Obes. 2008;9(2):140–50. doi:10.1111/j.1467-789X.2007.00464.x.
79. Organization WH. WHO recommendations for Prevention and treatment of pre-eclampsia and eclampsia. WHO Library Cataloguing-in-Publication Data. 2011.
80. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84. doi:10.1016/s0140-6736(08)60074-4.